Doctor profile · Federal record
Dr. JAMES UYEKI, M.D.
Medical Oncology Physician (CMS: MEDICAL ONCOLOGY) · Internal Medicine Physician · Hematology (Internal Medicine) Physician · AUSTIN, TX
- NPI 1124187927
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 29 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
4101 JAMES CASEY ST STE 100
AUSTIN, TX 787451145
(512) 447-2202
fax (512) 447-5337 - Additional location
-
1308 Wonder World Dr
San Marcos, TX 786667532
(512) 396-5199
fax (512) 396-5206 - Mailing address
-
PO BOX 911230
DALLAS, TX 753911230
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- November 2, 2022
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #L9944
- Medicaid (3)
- TX #177767403 · TX #177767402 · TX #177767401
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1124187927. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
408,789
Distinct HCPCS
10
Medicare allowed
$8,359,179
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 69,870 | 59 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 67,700 | 63 | $54 | |
J9299 |
Injection, nivolumab, 1 mg | 54,960 | 25 | $30 | |
J1756 |
Injection, iron sucrose, 1 mg | 53,700 | 73 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 24,120 | 21 | $48 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 19,345 | 17 | $3 | |
J9267 |
Injection, paclitaxel, 1 mg | 16,158 | 30 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 15,000 | 41 | $23 | |
J1453 |
Injection, fosaprepitant, 1 mg | 12,900 | 19 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 11,760 | 15 | $0 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 1,866. This provider delivers 219× the peer median.Open Payments
Industry payments received
All-time total
$49
Transactions
3
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $20.40 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $17.02 | |
| PFIZER INC. | 1 | $11.88 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,050
Patients
295
Total drug cost
$389,425
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 118 | 32 | $824 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 112 | 26 | $8,018 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 111 | 36 | $3,506 |
| Letrozole | Generic | 85 | 25 | $2,336 |
| Dexamethasone | Generic | 71 | 23 | $469 |
| Gabapentin | Generic | 68 | 17 | $1,112 |
| Xarelto (Rivaroxaban) | Brand | 64 | 18 | $72,610 |
| Allopurinol | Generic | 63 | 21 | $601 |
| Levothyroxine Sodium | Generic | 62 | 24 | $679 |
| Ondansetron Odt (Ondansetron) | Brand | 54 | 28 | $763 |